Can I get urothelial cancer even after undergoing treatment?

Hello,

Welcome to icliniq.com.

I understand your concern.

I understand how concerns about recurrence can weigh heavily even after successful treatment. Urothelial cancer, particularly of the bladder, does have a relatively high risk of recurrence, especially within the first few years following treatment. The recurrence rate can vary based on the tumor's grade, stage, and whether it was non-muscle invasive or muscle-invasive at diagnosis. This is why regular follow-up with imaging, urine tests, and sometimes cystoscopy is critical.

As for preventive measures, staying smoke-free (if you previously smoked), maintaining hydration, and following your oncologist’s surveillance plan are essential. Some patients with non-muscle invasive cancer may receive intravesical therapies such as bacillus calmette–guérin (BCG) or chemotherapy to reduce recurrence risk.

In terms of new therapies, there have been promising advances:

• Immunotherapy (especially immune checkpoint inhibitors such as Atezolizumab or Pembrolizumab) is now a standard option for patients with advanced or recurrent disease and is being studied in earlier stages.

• Targeted therapies (such as fibroblast growth factor receptor inhibitors) are used in patients with specific genetic mutations.

• Ongoing clinical trials are investigating vaccine therapies, combination immunotherapies, and novel intravesical agents to further reduce recurrence and improve survival.

The latest research focuses on personalizing treatment based on tumor genetics and immune response, which may significantly improve long-term outcomes in the near future.

It is excellent that you are staying proactive, maintaining follow-up, and discussing new treatment options with your care team, which can help you stay ahead and improve your long-term outlook.

I hope you are satisfied with my answer. For further queries, you can consult me at iCliniq.

Thank you.